Navigation Links
Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series
Date:11/20/2008

NEW YORK, Nov. 20 /PRNewswire/ -- Clinical data from a prospective registry presented this week at the 35th Annual Veith Symposium shows DVT treatment with the Trellis(R) Peripheral Infusion System from Bacchus Vascular, Inc. (Santa Clara, CA) successfully breaks up the blood clot in most patients in about 20 minutes.

This technique, called isolated pharmacomechanical thrombolysis, restores blood flow more quickly and safely than current catheter-directed thrombolysis (CDT) techniques. It provides an important adjunct to anti-coagulation alone, the current standard of care, which does not break up the existing clot but simply prevents further clot from forming.

Alan M. Dietzek, MD, Chief of Vascular and Endovascular Surgery at Danbury Hospital, Danbury, Connecticut reported the latest outcomes from the manufacturer's registry of clinical results with the Trellis System at over 360 hospitals in the U.S. and internationally.

In a total of 1,409 limbs treated in 1,304 patients, Grades II and III lysis with restoration of patency in patients with all clot chronicities were achieved in 95% of cases. The vast majority of cases (> 83%) were completed in less than two hours in the single-setting of an interventional suite; and the usage of the Trellis System was typically around 20 minutes. No follow-up monitoring in a costly critical care or intensive care unit was typically needed with the Trellis System, in contrast to this requirement of CDT procedures.

There were no reported bleeding complications related to the Trellis device in acute follow up and the dosage of thrombolytic drugs such as t-PA was reduced by 30% with use of the Trellis device compared to CDT.

"Profound changes in the treatment paradigm for DVT are now underway, as evidenced by the U.S. Surgeon General's recent DVT Call to Action," said Dr. Dietzek. "New clinical guidelines in 2008 from the American Colleg
'/>"/>

SOURCE Bacchus Vascular, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Trellis(R) Catheter Removes Blood Clots Quickly, Restoring Blood Flow in 771 Deep Vein Thrombosis (DVT) Patients
2. Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD)
3. Use of PressureWire(R) Yields a More Accurate Assessment of Translesion Pressure Gradients in Peripheral Vasculature, Two New Studies Report
4. Interim Safety Analysis Supports Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-cell Lymphoma
5. Rifalazil Trial (PROVIDENCE-1) Fails to Provide Significant Clinical Benefit in Patients With Peripheral Arterial Disease
6. ActivBiotics to Present Results of Pivotal Study in the Treatment of Peripheral Arterial Disease at AHA Meeting
7. Edwards Resilient Trial Demonstrates Statistically Superior Results for Treating Peripheral Arterial Disease in the Leg
8. Peripheral Arterial Disease to be Treated With New Medicated Stent in Trial at Montefiore
9. Interim Response and Safety Analyses Support Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma
10. Phase I/II Study of Targeted Gene Delivery In Vivo - Intravenous Infusions of REXIN-G - Demonstrates Dose-Dependent Anti-Tumor Activity Without Toxicity in Patients With Progressive Chemo-Resistant Bone and Soft Tissue Sarcoma (ASCO 2008)
11. TARGETED GENE DELIVERY SIGNALS CANCER VACCINATION IN VIVO: Intravenous Infusions of Rexin-G Followed by Reximmune-C Induce Tumor Necrosis and Recruitment of Tumor Infiltrating Lymphocytes in Cancerous Lesions (ASCO 2008)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...TY, Nov. 27 Booth - 3646...: VAR ), a premier supplier of X-ray tubes and f...s full range of detectors at the RSNA Annual Meeti... 2009. Varian will also be exhibiting X-ray tube ...ialized cancer treatment technologies. ,, Vari...
(Date:11/27/2009)...v. 27 At the upcoming Radiological...arting Sunday, Royal Philips Electronics ( PHG, AE... imaging and informatics solutions designed to dir...providers, by delivering meaningful imaging innova...ce points and easy upgradability. This focus will...
(Date:11/25/2009)...Calif., Nov. 25 Praxis Electronic ...he American Academy of Family Physicians, (AAFP) F...sfaction Survey for improving medical quality, hea...cal for new ARRA Stimulus legislation. Praxis also...a positive effect in determining their salary. Fin...
Breaking Medicine Technology:Varian Medical Systems to Highlight the Latest Digital Detectors, X-ray Tubes and Cancer Treatment Technology at the Radiological Society of North America (RSNA) Annual Meeting in Chicago 2Philips Helps Hospitals Strike Balance Between Innovation and Value 2Philips Helps Hospitals Strike Balance Between Innovation and Value 3Philips Helps Hospitals Strike Balance Between Innovation and Value 4Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2National Foundation for Infectious Diseases 28NFID 29 Survey 3A Parents More Flu Aware and More Likely to Get Kids Vaccinated 5552 1National Foundation for Infectious Diseases 28NFID 29 Survey 3A Parents More Flu Aware and More Likely to Get Kids Vaccinated 5552 2National Foundation for Infectious Diseases 28NFID 29 Survey 3A Parents More Flu Aware and More Likely to Get Kids Vaccinated 5552 3National Foundation for Infectious Diseases 28NFID 29 Survey 3A Parents More Flu Aware and More Likely to Get Kids Vaccinated 5552 4Lifeclinic to Engage People Over 50 in Utilizing Technology and Wellness at AARP 2009 Event and Expo 59738 1Lifeclinic to Engage People Over 50 in Utilizing Technology and Wellness at AARP 2009 Event and Expo 59738 2Lifeclinic to Engage People Over 50 in Utilizing Technology and Wellness at AARP 2009 Event and Expo 59738 3Evosys a Major Player in the Oracle E Business Suite Implementation Support and Consultancy Services Domain has Recently Been Awarded Oracles Certi 59733 1Evosys a Major Player in the Oracle E Business Suite Implementation Support and Consultancy Services Domain has Recently Been Awarded Oracles Certi 59733 2Evosys a Major Player in the Oracle E Business Suite Implementation Support and Consultancy Services Domain has Recently Been Awarded Oracles Certi 59733 3
...CHARLOTTE, N.C., July 9 USHIFU, LLC, a global lea...und (HIFU) technology, is proud,to announce sponso...try,(SIHR), along with co-sponsors Misonix, Inc. (...., (THS). The SIHR is the first and only worldwide...cer treatment using HIFU.,It was established to of...
...SOUTH SAN FRANCISCO, July 9 Cerimon Pharmaceutica...II proof-of-concept study of,Simulect(R) (basilixi...,chronic and potentially sight-threatening inflamm...lacebo-controlled study will evaluate the,safety a...56 patients.,During the study, patients will under...
Other Medicine Technology:Sonablate(R) International HIFU Registry is the First Worldwide HIFU Clinical Registry for Prostate Cancer Treatments 2Sonablate(R) International HIFU Registry is the First Worldwide HIFU Clinical Registry for Prostate Cancer Treatments 3Cerimon Pharmaceuticals Initiates Phase II Study to Evaluate Simulect(R) (Basiliximab) for Noninfectious Uveitis 2
(Date:11/27/2009)...DALLAS, Nov. 27 Conside...dure only 25 years ago, solid organ transplantatio... to the extraordinary men and women who gathered a...eaders came together from medical centers around t...or Regional Transplant Institute (BRTI), one of th...
(Date:11/27/2009)...IBBUTZ SHAMIR, Israel, Nov. 27 /PRNewswire-FirstCa... ) ( "Shamir" ), a leading provider of innovative ...ket, announced today that its board of directors h...e amount of US$ 10 million (approximately NIS 37.6...ative rate of exchange), or approximately US$ 0.60...
(Date:11/27/2009)... , SEATTLE, Nov. 27 ...ved record-high Thanksgiving traffic numbers, with...nksgiving, providing a clear picture of what was s... average Thanksgiving meal in 2009 weighed in at 2...om last year,s feast. According to the Allrecipes ...
(Date:11/27/2009)... Three new interactive anatomy educat...p; Wilkins expand health sciences learning opportu... Durham, NC (Vocus) November 27, 2009 -- ...kins (LWW), a division of Wolters Kluwer Health, t...my education apps on the App Store. Clemente&rsquo...
(Date:11/26/2009)... sequestering drug tetrathiomolybdate (TM) has bee...t of Wilson disease, a disease caused by an overlo... much is known. Very little, however, is known abo...A new study led by Northwestern University researc...e-dimensional structure of TM bound to copper-load...
Breaking Medicine News(10 mins):Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 3Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3
...supplement no substitute for old-fashioned hard wo...ay News) -- Taking creatine doesn,t improve exerci... pulmonary disease (COPD), a U.K. study reports. ...eived either creatine or a placebo during a seven-...
... Mark Merritt, President,of the Pharmaceutical Ca...atement in response to new comparative effectivene... Finance Committee Chair Max Baucus,(D-Mont.) and ...ove quality through more objective,information and...
...ther treating the breathing disorder cuts the dang...althDay News) -- The interrupted nighttime breathi...dying, Australian researchers report. , Earlier st...s new study suggests that the risk is present amon...
...searchers at the University of Pennsylvania School... FOXA2 controls genes that maintain the proper lev...s for new therapies to treat diseases that involve...ll bladder and transported through ducts to the sm...
... Vertrue, for the second year in a row, is g...o families and children who need it the most. , ...1, 2008 -- For the second year in a row, http://w...ry of Vertrue, are giving away $1 million in disco...
... For the second consecutive year, Omega Inst...nebeck campus August 15-17, for professionals and ...plore the latest research and development in treat...host an important conference at its Rhinebeck camp...
Other Medicine News:Health News:Creatine Has Negligible Effect on COPD Exercise Rehab 2Health News:Sleep Apnea Boosts Death Risk 2Health News:Sleep Apnea Boosts Death Risk 3Health News:Penn researchers find a new role for a 'Foxy Old Gene' 2Health News:Vertrue Incorporated and Feed The Children Join Forces to Give Away $1 Million in Aid to Families in Need 2Health News:Vertrue Incorporated and Feed The Children Join Forces to Give Away $1 Million in Aid to Families in Need 3Health News:Vertrue Incorporated and Feed The Children Join Forces to Give Away $1 Million in Aid to Families in Need 4Health News:Omega to Hold Conference: Autism Through the Life Span II 2Health News:Omega to Hold Conference: Autism Through the Life Span II 3
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
Medicine Products: